We have characterized the interaction between apolipoprotein E (apoE) and a
myloid beta peptide (A beta) in the soluble fraction of the cerebral cortex
of Alzheimer's disease (AD) and control subjects. Western blot analysis wi
th specific antibodies identified in both groups a complex composed of the
full-length apoE and A beta peptides ending at residues 40 and 42. The apoE
-A beta soluble aggregate is less stable in AD brains than in controls, whe
n treated with the anionic detergent SDS. The complex is present in signifi
cantly higher quantity in control than in AD brains, whereas in the insolub
le fraction an inverse correlation has previously been reported. Moreover,
in the AD subjects the A beta bound to apoE is more sensitive to protease d
igestion than is the unbound A beta. Taken together, our results indicate t
hat in normal brains apoE efficiently binds and sequesters A beta, preventi
ng its aggregation. In AD, the impaired apoE-A beta binding leads to the cr
itical accumulation of A beta, facilitating plaque formation.